See Credit Details Below
Overview
Why You Should Attend:
This Studio Briefing features a broad range of professionals engaged in controlled substances law, including expertise from the biopharmaceutical, consumer, banking and law firm perspectives. Our faculty review the Controlled Substances Act (CSA), the Drug Enforcement Agency and federal and state law considerations that shape the existing framework within which industries falling within their purview operate and share practical considerations for counsel representing clients in the arena.
What You Will Learn:
After completing this program, participants will be able to:
- Understand the role of the Controlled Substances Act, the Drug Enforcement Agency (DEA) and law enforcement in controlled substances law
- Review federal, state, and international legal considerations
- Understand DEA Drug Scheduling – reviewing schedules 1-5
Who Should Attend:
Lawyers counseling on matters pertaining to controlled substances implicating the Controlled Substances Act and relevant state and local laws should find this program to be helpful.
PLI’s Studio Briefings are on-demand video CLE programs that feature an intimate and engaging round table discussion format with legal and industry experts addressing a range of topics. Visit our landing page for our library of PLI Studio Briefings.